# MDBiolab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mdbiolab

- Industry: Pharmaceuticals
- Headquarters: Seoul, South Korea
- Total disclosed funding: $5.3M
- Latest round: Series A (Sep 15, 2019)
- Investors on record: 4

## About

Founded in 2017 and based in Seoul, South Korea, MDBiolab develops pharmaceutical treatments for kidney cancer.

## Funding rounds

- Series A, Sep 15, 2019, $5.3M — Hyundai Venture Investment, DSC Investment, LSK Investment, Ulmus Investment

## Investors

- Hyundai Venture Investment (https://capitalatlas.ai/funds/hyundai-venture-investment) — Series A
- DSC Investment (https://capitalatlas.ai/funds/dsc-investment) — Series A
- LSK Investment (https://capitalatlas.ai/funds/lsk-investment) — Series A
- Ulmus Investment (https://capitalatlas.ai/funds/ulmus-investment) — Series A